The deal, due to close in early 2022, is for Baylis Medical Company and its products focused on making it safer for surgeons to get at the left side of the heart. Boston Scientific, which specializes in devices for less invasive surgeries, will add Baylis’s products to its existing cardiology division. The deal doesn’t include Baylis Medical Technologies, which makes products for radiology and neurosurgery and also does contract manufacturing. (The Logic)
In-depth, agenda-setting reporting
Great journalism delivered straight to your inbox.
Digital car-auction platform E Automotive files for TSX IPO
Union takes umbrage after Stellantis cuts Windsor plant to single shift, citing chip shortage
Canadian miner Noront now favours Wyloo Metals in bidding war with BHP
Competition Bureau investigating Google’s YouTube ad practices
Best business newsletter in Canada
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership to The Logic Council
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our newsroom team and special guests.